incorporation of basic fibroblast growth factor by a layer-by-layer assembly technique to produce...
TRANSCRIPT
Incorporation of Basic Fibroblast Growth Factorby a Layer-by-Layer Assembly Technique to ProduceBioactive Substrates
Lie Ma, Jie Zhou, Changyou Gao, Jiacong Shen
Key Laboratory of Macromolecular Synthesis and Functionalization, Ministry of Education, Department of PolymerScience and Engineering, Zhejiang University, Hangzhou 310027, China
Received 30 April 2006; revised 5 January 2007; accepted 10 January 2007Published online 23 March 2007 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/jbm.b.30794
Abstract: Basic fibroblast growth factor (bFGF) was immobilized onto quartz slides and
collagen films by assembly with chondroitin sulfate (CS) in a layer-by-layer (LBL) manner.
First, the LBL-deposition process on the amino-silanized quartz slides was monitored by UV–
vis spectroscopy and water contact angle measurement. By substituting the normal bFGF with
rhodamine-labeled one (Rd-bFGF), a linear increase of the absorbance versus bilayer number
was recorded. The water contact angle oscillated between the odd CS and the even bFGF
layers, demonstrating the alternating change of the surface chemistry. Scanning force
microscopy (SFM) revealed that the surface topography was altered slightly after multilayer
assembly. In vitro incubation of the CS/bFGF multilayers in PBS showed that *30% of the
incorporated bFGF was released within 8 days. In vitro cell culture found that the fibroblasts
showed star-like morphology with plenty of pseudopods on the bFGF-incorporated collagen
film after cultured for 1 day, and the collagen films assembled with bFGF possess improved
bioactivity than that of the virgin one and the bFGF control. Since the immobilized growth
factors can maximally retain their bioactivity, the LBL assembly would be a potential
approach to construct a bioactive substrate for biomedical applications. ' 2007 Wiley Periodicals,
Inc. J Biomed Mater Res Part B: Appl Biomater 83B: 285–292, 2007
Keywords: layer-by-layer; cell-materials interaction; interface; growth factor; collagen
INTRODUCTION
Tissue engineering is emerging as a useful strategy for
replacement and regeneration of damaged organs or tis-
sues.1,2 Nowadays, it is regarded as one of the most prom-
ising ways in tissue engineering to induce the natural
regeneration mechanism of the body. For this purpose,
incorporation of various signal generating molecules is gen-
erally adopted, since the signals can regulate cells’ prolifer-
ation and differentiation in the body.3–5 These signals can
be generated from growth factors, cell-extracellular matrix
(ECM), and cell–cell interactions, as well as from physi-
cal–chemical and mechanical stimuli.6,7
It is known that various growth factors are always
involved in tissue regeneration. They can regulate prolifera-
tion and differentiation of different types of cells in the tis-
sue healing process. Therefore, many efforts have been
devoted to constructing bioactive substrates by incorporation
of growth factors related to tissue regeneration. Among
which basic fibroblast growth factor (bFGF) has been widely
applied in the regeneration of bone,8 cartilage,9 skin,10 and
nerve.11,12 In human body, bFGF always binds with ECM
components such as polysaccharides by intermolecular inter-
actions. When simply added into solution, however, the
bFGF will lose its bioactivity quickly. Therefore, many car-
rier systems such as gels and microparticles have been
developed to deliver the growth factors.13,14 Control over
the concentration, local duration and spatial distribution of
the growth factors are the key factors for their utility and ef-
ficacy. Recent advances have been made in developing poly-
meric delivery systems to achieve this control.15,16
In the past decades, layer-by-layer (LBL) assembly ini-
tially introduced by Decher has been developed rapidly and
broadly.17 The principle of the LBL assembly technique is
based on the alternate adsorption of polyelectrolytes with
opposite charge. Because of the rich choice of the
Correspondence to: C. Gao (e-mail: [email protected])Contract grant sponsor: Major State Basic Research Program of China; contract
grant number: 2005CB623902Contract grant sponsor: Ph.D. Programs Foundation of Ministry of Education of
China; contract grant number: 20050335035Contract grant sponsor: Natural Science Foundation of China; contract grant
number: 20434030Contract grant sponsor: National Science Fund for Distinguished Young Scholars
of China; contract grant number: 50425311
' 2007 Wiley Periodicals, Inc.
285
assembled polyelectrolytes and less restriction of assembled
substrate, this technique has been extended to assemble dyes,
conducting polymers, and biological macromolecules.18–20
More recently, attempts have been made to seek practical
applications too, particularly in biomedical fields. For exam-
ple, LBL assembly of ECM components on synthetic poly-
mers was used to create a cytocompatible interface.21
Moreover, polysaccharides, nucleic acids, and functional
peptides are all employed in modification of biomaterials by
the LBL technique.22,23 Yet, incorporation of cell growth
factors by the LBL technique is rarely reported so far.
The purpose of this work is to explore the feasibility of
immobilizing cell growth factors via the LBL assembly
technique. Exemplified here with bFGF (positively charged
at neutral pH), the incorporation is accomplished by inter-
action with a negatively charged polysaccharide, chondroi-
tin-4-sulfate (CS). To monitor the LBL-deposition process,
amino-silanized quartz slides are first adopted for their high
transparency in UV–vis region. Assembly of bFGF and CS
is then extended to collagen films to seek a practical appli-
cation. Accordingly, the bioactivity of the modified colla-
gen substrates is evaluated by in vitro cell culture.
MATERIALS AND METHODS
Materials
Collagen type I was isolated from fresh bovine tendons by
a trypsin digestion and acetic acid extraction method.
Recombinant bFGF (freeze-dried powder, 500 U/mg) was
obtained from Changchun ChangSheng Gene Pharmaceuti-
cal (China). CS and trypsin (250 U/mg) were purchased
from Sigma (USA). All other reagents and solvents were of
analytical grade and used as received.
Rhodamine-labeled bFGF (Rd-bFGF) was prepared by
incubating the bFGF solution in 0.2 mg/mL rhodamine B
isothiocyanate at 48C for 48 h. The unreacted dyes were
dialyzed off in distilled water for 4 weeks. The dialyzing
solution was changed every 3 days.
Preparation of Substrates
For the sake of monitoring the assembly process, the CS/
bFGF multilayers were first constructed on quartz slides.
Before assembly, the quartz slides were cleaned in a
freshly prepared \piranha" solution (7:3 concentrated 98%
H2SO4:30% H2O2) for 5 min, and then were rinsed exten-
sively with water. The cleaned quartz slides were treated in
2% (v/v) c-aminopropyltriethoxysilane (APTES)/95% etha-
nol solution for 20 min, and then were dehydrated at
1108C for 1 h to obtain the amino-silanized quartz slides.
The collagen films were prepared by casting 1% (w/v)
collagen/0.5% acetic acid solution on a stainless steel plate
and then dried at 258C for 48 h. The films were further
treated at 1058C under reduced pressure (<0.2 mbar) for
another 24 h.
LBL-Deposition Process
First, all the substrates were incubated into 3% (w/v) acetic
acid solution for 15 min to obtain the positively charged
surfaces. Then, the substrates were immersed into CS solu-
tion (1 mg/mL with 0.1M NaCl, pH 5.6) for 15 min at
room temperature, followed by rinsing with 0.1M NaCl so-
lution for three times. Subsequently, the substrates were
dipped into bFGF/PBS solution (10 mg/mL) for 15 min, fol-
lowed by rinsing with PBS (pH 7.4) for three times. Fur-
ther deposition of the CS/bFGF on the substrates was
accomplished by repeating the same cycle as shown in
Figure 1. The cycle was repeated for n times to obtain
substrates with (CS/bFGF)n multilayers.
Characterization
The deposition process of the CS/bFGF multilayers on the
quartz slide was monitored with a UV–vis spectrophotome-
ter (CARY 100 BIO, America) by substituting the normal
bFGF with Rd-bFGF. Oscillation of water contact angle
between layers was measured on a DSA10-MK2 contact
angle measuring system from Kruss in a sessile drop man-
ner. The morphology of the multilayers on the quartz slides
was characterized with a scanning force microscope (SFM)
(SPI3800N, Seiko) in a dynamic force mode. The cross-
section image of the collagen film assembled with (CS/
Rd-bFGF)10 multilayers was recorded with a confocal laser
scanning microscope (CLSM) (Bio-Rad Radiance 2100).
Fibroblast Isolation and Culture
Fibroblasts used in this study were isolated from human
foreskin by collagenase digestion. Briefly, the epidermis
and subcutaneous tissue of human foreskin were removed
by a scalpel. The residual dermis was diced into 0.5–
1 mm3 sized tissues, and washed with PBS supplemented
Figure 1. Schematic illustration to show the layer-by-layer assembly
of chondroitin sulfate (CS) and basic fibroblast growth factor (bFGF)
on an amino-silanized solid substrate such as quartz slide and col-lagen film. [Color figure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
286 MA ET AL.
Journal of Biomedical Materials Research Part B: Applied BiomaterialsDOI 10.1002/jbmb
with penicillin (100 U/mL) and streptomycin (100 U/mL)
for three times. Then, these dermis pieces were placed in a
spinner flask (Falcon) containing 10 mL 1 mg/mL collage-
nase (type I, Sigma) in Dulbecco’s modified Eagle medium
(DMEM, Gibco) supplemented with penicillin (100 U/mL)
and streptomycin (100 U/mL). After the dermis pieces were
digested in an incubator (378C, 5% CO2) for 5 h, suitable
amount of DMEM supplemented with penicillin (100 U/mL),
streptomycin (100 U/mL), and 10% fetal bovine serum
(FBS) (complete medium) was added to terminate the diges-
tion. The digesting solution was filtered through a copper
mesh (cell strainer, 200 meshes), and then was centrifuged at
1000 rpm for 10 min. After discarded the supernatant, com-
plete medium was added to suspend the cells. The fibroblasts
were cultured in culture plates at 378C, 5% CO2, and 95%
humidity. The culture medium was changed every 3 days.
Cell Morphology
Cells were passaged at confluence and fourth to eighth pas-
sage fibroblasts were used to evaluate the bioactivity of the
collagen films. After cell-seeding for 1 and 7 days, the vir-
gin collagen films and the (CS/bFGF)5-modified collagen
films were washed with PBS for two times, and then were
treated in 5 mg/mL fluorescein diacetate (FDA) solution for
15 min. Only viable cells could metabolize FDA (nonfluor-
escent) to fluorescence probe. After removal of the
unreacted FDA by two washings in PBS, 1 mL complete
medium was added. Fluorescent images of the viable fibro-
blasts were recorded by CLSM.
Cell Attachment and Proliferation Behaviors
All the samples were sterilized with ethylene oxide before
cell seeding. The films were placed on the bottom of a well
of 96-well tissue culture polystyrene plate (TCPS, Falcon).
Into each well, 5000 human dermal fibroblasts were seeded.
Meanwhile, a blank TCPS well was seeded with the same
number of cells and supplemented with 0.2 mg bFGF (bFGF
control). The number of fibroblasts on different samples was
quantified by a cell-counting method. Briefly, the cells at
each interval were digested by 0.25% (w/v) trypsin for 10–15
min at 378C. The cell number was then counted under a hae-
macytometer. In these experiments, no serum was used. The
culture medium (without serum) was changed every 3 days.
The cell attachment ratio was defined as the ratio of the
remaining cell number on the substrate after 12 h culture to
the initial number. The cell-proliferation behavior was eval-
uated by examining the time-dependent change of fibro-
blast number. Each value was averaged from three parallel
measurements.
Statistical Analysis
Data are expressed as the mean 6 SD. Statistical analysis
was performed using two-population Student’s t test. The
significant level was set as p < 0.05.
RESULTS
The LBL-Deposition Process
The change of absorbance of the rhodamine labeled bFGF
as a function of layer number is presented in Figure 2. It
shows that the absorbance of the multilayers increased
almost linearly with the layer number, demonstrating that
bFGF was surely assembled on the slide in a LBL manner.
Figure 3 shows the alternation of water contact angle as a
function of layer number. The samples with odd and even
number represent CS and bFGF as the outmost layer,
respectively. Basically, the water contact angles oscillated
between 558–608 (CS as the outmost layer) and 658–708(bFGF as the outmost layer). This result implies that the
CS layer is more hydrophilic than the bFGF layer, and
indicates that they are deposited in a LBL manner.
Figure 2. Absorbance (*560 nm) of Rd-bFGF in the CS/Rd-bFGF
multilayers as a function of the layer number.
Figure 3. Water contact angle on the assembled substrate as a
function of layer number. Odd and even numbers represent CS andbFGF as the outmost layer, respectively.
287INCORPORATION OF bFGF BY A LAYER-BY-LAYER ASSEMBLY TECHNIQUE
Journal of Biomedical Materials Research Part B: Applied BiomaterialsDOI 10.1002/jbmb
The change of the surface topography before and after
LBL deposition was detected by SFM (Figure 4). The
untreated quartz slide shows a relative smooth topography
with an average surface roughness (RMS) of 0.68 nm
[Figure 4(a)]. After treated with APTES, tiny dots emerged
on the quartz surface, leading to a rougher surface with an
average RMS of 0.94 nm [Figure 4(b)]. These dots could
be the product of inhomogeneous self-crosslinking of
APTES. After assembled with one layer of CS, the amino-silan-
ized surface became smoother (RMS 0.81 nm) [Figure 4(c)],
implying the occurrence of surface coating. After deposi-
tion of five bilayers, a more irregular and rougher surface
(RMS 1.1 nm) was obtained [Figure 4(d)].
Stability of the Assembled Multilayers
To detect the stability of the incorporated bFGF, a quartz slide
deposited with 10 bilayers of CS and Rd-bFGF was immersed
into PBS (pH 7.4). The absorbance from the quartz slide was
then recorded as a function of time by UV–vis spectroscopy
(Figure 5). It shows that in the early 4 h, no significant
decrease of absorbance had been measured. After immersed
for 12 h, the absorbance reduced *8%, demonstrating that
the CS/bFGF multilayers have suitable stability in the initial
stage. A more quick decay of the absorbance occurred
between 12 and 48 h. The cumulative release amount of
bFGF reached to about 20% at 48 h. Then, the bFGF in the
multilayers could be released up to 8 days at a relatively slow
rate. Meanwhile, the topography change after immersion in
PBS was also examined as shown in Figure 6. The multilayer
surface lost their irregular topography gradually and became
smoother with the prolongation of immersion time.
Evaluation of the Bioactivity
Figure 7 shows the cross-section of the collagen film
assembled with 10 bilayers of CS/Rd-bFGF, which was
observed directly by CLSM. It shows that there exists a red
Figure 4. SFM images to show the quartz slide surface (a), amino-silanized quartz slide surface (b),
surfaces assembled with one layer of CS (c), and five bilayers of CS/bFGF (d). [Color figure can beviewed in the online issue, which is available at www.interscience.wiley.com.]
Figure 5. Absorbance (*560 nm) of (CS/Rd-bFGF)10 multilayers as
a function of time. The multilayers deposited on a 1 3 2 cm2 quartzslide were immersed in PBS at room temperature.
288 MA ET AL.
Journal of Biomedical Materials Research Part B: Applied BiomaterialsDOI 10.1002/jbmb
ultrathin layer on each side of the film, which is exclu-
sively attributed to the emission of the Rd-bFGF.
Cell Morphology. The morphology of the fibroblasts
seeded on different substrates for different time was com-
pared (Figure 8). The images of 1 day show that the fibro-
blasts could adhere and spread on all the substrates. However,
the fibroblasts on the virgin collagen film exhibit polygonal
morphology with few pseudopods. By contrast, the cells on
the bFGF incorporated substrate show the star-like morphol-
ogy with plenty of pseudopods, indicating that the cells might
be in the state preparing for differentiation [Figure 8(a,c)]. Af-
ter 7 days of culture, more cells with typical fibroblast mor-
phology were observed on the bFGF-assembled substrate
than that on the unmodified one [Figure 8(c,d)].
Cell Attachment and Proliferation Behaviors. The
attachment ratios of fibroblasts on different kinds of sam-
ples are compared in Figure 9. No significant difference
(p > 0.05) was found between these samples. Figure 10
compares the change of the cell number on these samples
with the culture time. The fibroblasts proliferated more rap-
idly at the first day on the (CS/bFGF)5 multilayer modified
film and the bFGF control than on the virgin collagen film
(p < 0.05). Although no significant difference was found
between the number of cells cultured on the (CS/bFGF)5multilayer modified film and the bFGF control. At day 2,
more fibroblasts was detected on the (CS/bFGF)5 multilayer
modified film than that on the bFGF control and the virgin
collagen film. Although the cells continued dividing, no
significant difference was found for all the samples
between day 2 and day 4. After day 4, the cell number still
kept at a relatively high level without obvious change.
DISCUSSION
In this work, the bioactive substrates were constructed by
incorporation of bFGF in a LBL manner. First, the deposi-
Figure 6. SFM images to show the surface topography of the (CS/bFGF)10 multilayers before (a)and after the multilayers were immersed in PBS (pH 7.4) for (b) 2, (c) 5, and (d) 7 days. [Color figure
can be viewed in the online issue, which is available at www.interscience.wiley.com.]
Figure 7. CLSM image to show cross-section of the collagen film
assembled with 10 bilayers of CS/Rd-bFGF. [Color figure can be viewedin the online issue, which is available at www.interscience.wiley.com.]
289INCORPORATION OF bFGF BY A LAYER-BY-LAYER ASSEMBLY TECHNIQUE
Journal of Biomedical Materials Research Part B: Applied BiomaterialsDOI 10.1002/jbmb
tion process was monitored by the UV–vis spectroscopy to
testify the realization of the LBL assembly. In consideration
of the poor transparency of the collagen films in UV–vis
region, quartz slides were used to monitor the LBL growth
process of CS and bFGF. In addition, to record the absorb-
ance change of bFGF with the deposition process, the nor-
mal bFGF was substituted by Rd-bFGF, which shows the
maximum absorbance at about 560 nm. The linear increase
of the Rd-bFGF absorbance with the layer number proved
that bFGF has been surely incorporated on the slide in a
LBL manner. It is worth mentioning that the bFGF amount
in the first bilayers was somewhat larger than that of the
latter bilayers. This could be caused by additional physical
adsorption besides the charge interaction.
In general, surface wettability of a material is mainly
decided by its superficial layer. Therefore, the oscillation of
the surface wettability caused by the different building
blocks (either CS or bFGF as the outmost layer) can be con-
veniently tracked by water contact angle, and accordingly
can be used to prove the LBL-deposition process. Since
bFGF is an amphiphilic protein, all the samples were dried at
378C for 3 h before the measurements. This would benefit
the hydrophobic domains of bFGF to expose to the layer sur-
face, so that larger difference of wettability can be achieved.
The surface morphology of the material is one of the
key aspects determining the cell behaviors. Therefore, the
surface morphology after deposition should be examined.
The SFM images demonstrated that, in general, the modi-
fied surface is very smooth and the topography change of
the quartz surface is very minimal. Thus, one can exclude
the influence of surface morphology on the cell behaviors.
The stability of the assembled multilayers against incu-
bation is crucial for the growth factor to perform biological
function. Multilayers with low stability will dissociate
quickly and the bioactivity of the growth factor will be rap-
idly lost. On the other hand, the growth factor in a bioac-
tive substrate should also be released in a suitable manner
to exert necessary biological response. The PBS-immersion
test showed that the release of the incorporated bFGF taken
place mostly in the period from 12 to 48 h, in which the
fibroblasts are commonly in the proliferation stage. Then,
the remaining bFGF can be released steadily for up to 8
days. This sustaining release could accelerate the cells pro-
liferation in a relatively long time.
The bioactivity of the bFGF in the as-prepared multi-
layers was assessed by in vitro fibroblast culture. For this
Figure 8. CLSM images to show the viable fibroblasts on the virgin
collagen films (a,c) and the (CS/bFGF)5-modified collagen films (b,d)
after cultured for 1 day (a,b) and 7 days (c,d). Viable cells were
stained green (bright color) with fluorescein diacetate (FDA). [Colorfigure can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
Figure 9. Cell attachment ratio on virgin collagen film, bFGF control
(0.2 mg/well), and (CS/bFGF)5 multilayer modified collagen film. 96-well TCPS was used and the cells were cultured for 12 h.
Figure 10. In vitro cell proliferation on virgin collagen film, bFGFcontrol (0.2 mg/well), and (CS/bFGF)5 multilayer modified collagen
film as a function of culture time. *Indicates p < 0.05.
290 MA ET AL.
Journal of Biomedical Materials Research Part B: Applied BiomaterialsDOI 10.1002/jbmb
purpose, instead of quartz slide, collagen film was
employed as substrate to assemble bFGF, since this mate-
rial has a wide application in biomedical field. However, it
was hard to monitor the LBL process directly on the colla-
gen film by methods such as UV–vis spectroscopy because
of the translucence of the collagen film. Nevertheless, we
would expect similar multilayer structure on the collagen
film. Therefore, CLSM was performed to observe directly
the cross-section of the collagen film deposited with CS/
Rd-bFGF multilayers. It has to note that it is not reasonable
to judge the multilayer thickness from the CLSM image,
because the best resolution of CLSM is practically larger
than 300 nm at an excitation wavelength of 543 nm.
Although the layer structure and thickness cannot be
derived from this observation, the incorporation of bFGF is
undoubtedly confirmed.
Normally, the interaction processes between cells and
substrate can be divided into several stages such as adher-
ing stage, spreading stage, proliferation stage, and so forth.
Hence, the cell attachment and proliferation behaviors are
the key factors to determine the function of the incorpo-
rated bFGF. There has no significant difference of the cell
attachment ratio between the virgin collagen film and the
bFGF-modified one. The result is reasonable, because
bFGF has, in most cases, no positive effect on the adhering
performance of fibroblasts.24
Finally, the cell-proliferation behaviors were recorded
by measuring the cell number on the different substrates
with the culture time. On the basis of the similar cell
attachment ratio, the cell number at each interval can repre-
sent the cell-proliferation behavior. From the results of the
cell-proliferation test, one can conclude that (1) in the cul-
ture medium absence of serum, the supplement of bFGF,
regardless of its form, has positive effect on fibroblast pro-
liferation than the virgin collagen film, in particular, in the
initial stage; (2) the LBL-immobilized bFGF has a stronger
ability to accelerate the proliferation of fibroblasts than the
unimmobilized one. Taking into account the typical thick-
ness of a single layer (around 2 nm), the total amount of
bFGF in the (CS/bFGF)5 multilayers (double sides on the
collagen film) is estimated as 0.5 mg. According to Figure 5,
the released amount of bFGF is around 20%. Hence, the
maximal soluble amount of bFGF is *0.1 mg, only 50% of
the bFGF control. One can then further conclude that the
LBL immobilization can largely preserve the bioactivity of
the cell-growth factor.
CONCLUSIONS
Layer-by-layer assembly technique is successfully employed
to construct CS/bFGF multilayers on quartz slides and colla-
gen films. The linear increase of the absorbance and the oscil-
lation of contact angle between even and odd layers have
confirmed that the multilayers are constructed in a LBL man-
ner. The deposited CS/bFGF multilayers can be partly disas-
sembled to release the deposited bFGF at a proper rate. The
cell-proliferation test and the cell morphology observation
demonstrate that the collagen films assembled with bFGF
possess an improved bioactivity than that of the virgin one
and the bFGF control, demonstrating that the LBL immobili-
zation can largely preserve the bioactivity of the cell-growth
factor. Thus, it is regarded as a promising approach to incor-
porate cell-growth factors, which can be extended to modify-
ing 3D scaffolds too and is under investigation now.
REFERENCES
1. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920–926.
2. Lavik E, Langer R. Tissue engineering: Current state and per-spectives. Appl Microbiol Biotechnol 2004;65:1–8.
3. Zisch AH, Lutolf MP, Hubbell JA. Biopolymeric delivery mat-rices for angiogenic growth factors. Cardiovasc Pathol 2003;12:295–310.
4. Takezawa T. A strategy for the development of tissue engi-neering scaffolds that regulate cell behavior. Biomaterials2003;24:2267–2275.
5. Patel ZS, Mikos AG. Angiogenesis with biomaterial-baseddrug- and cell-delivery systems. J Biomater Sci Polym E 2004;15:701–726.
6. Rosso F, Giordano A, Barbarisi M, Barbarisi A. From cell-ECM interactions to tissue engineering. J Cell Physiol 2004;199:174–180.
7. Hench LL, Polak JM. Third-generation biomedical materials.Science 2002;295:1014–1017.
8. Nakahara T, Nakamura T, Kobayashi E, Inoue M, Shigeno K,Tabata Y, Eto K, Shimizu Y. Novel approach to regenerationof periodontal tissues based on in situ tissue engineering:Effects of controlled release of basic fibroblast growth factorfrom a sandwich membrane. Tissue Eng 2003;9:153–162.
9. Ma ZW, Gao CY, Gong YH, Shen JC. Cartilage tissue engi-neering PLLA scaffold with surface immobilized collagen andbasic fibroblast growth factor. Biomaterials 2005;26:1253–1259.
10. Tanihara M, Suzuki Y, Yamamoto E, Noguchi A, MizushimaY. Sustained release of basic fibroblast growth factor andangiogenesis in a novel covalently crosslinked gel of heparinand alginate. J Biomed Mater Res 2001;56:216–221.
11. Ohta M, Suzuki Y, Chou H, Ishikawa N, Suzuki S, TaniharaM, Suzuki Y, Mizushima Y, Dezawa M, Ide C. Novel hepa-rin/alginate gel combined with basic fibroblast growth factorpromotes nerve regeneration in rat sciatic nerve. J BiomedMater Res A 2004;71:661–668.
12. Laquerriere A, Peulve P, Jin O, Tiollier J, Tardy M, VaudryH, Hemet J, Tadie M. Effect of basic fibroblast growth factorand a-melanocytic stimulating hormone on nerve regenerationthrough a collagen channel. Microsurgery 1994;15:203–210.
13. Lee JE, Kim SE, Kwon IC, Ahn HJ, Cho H, Lee SH, KimHJ, Seong SC, Lee MC. Effects of a chitosan scaffold con-taining TGF-b 1 encapsulated chitosan microspheres on invitro chondrocyte culture. Artif Organs 2004;28:829–839.
14. Tabata Y, Nagano A, Muniruzzaman M, Ikada Y. In vitrosorption and desorption of basic fibroblast growth factor frombiodegradable hydrogels. Biomaterials 1998;19:1781–1789.
15. Boontheekul T, Mooney DJ. Protein-based signaling systemsin tissue engineering. Curr Opin Biotech 2003;14:559–565.
16. Saltzman WM, Olbricht WL. Building drug delivery into tis-sue engineering. Nat Rev Drug Discov 2002;1:177–186.
17. Decher G. Fuzzy nanoassemblies: Toward layered polymericmulticomposites. Science 1997;277:1232–1237.
291INCORPORATION OF bFGF BY A LAYER-BY-LAYER ASSEMBLY TECHNIQUE
Journal of Biomedical Materials Research Part B: Applied BiomaterialsDOI 10.1002/jbmb
18. Kotov NA. Layer-by-layer self-assembly: The contribution ofhydrophobic interaction. Nanostructured Mater 1999;12:789–796.
19. Nicol E, Moussa A, Habib-Jiwan JL, Jonas AM. Layer-by-layer self-assembly of polyelectrolyte and the divalent salt offluorescein. J Photochem Photobiol A 2004;167:31–35.
20. Ferreira M, Fiorito PA, Oliveira ON, de Torresi SIC. Enzyme-mediated amperometric biosensors prepared with the layer-by-layer (LBL) adsorption technique. Biosens Bioelectron 2004;19:1611–1615.
21. Zhu YB, Gao CY, He T, Liu XY, Shen JC. Layer-by-layer as-sembly to modify poly(L-lactic acid) surface toward improving
its cytocompatibility to human endothelial cells. Biomacromole-cules 2003;4:446–452.
22. dos Santos DS, Riul A, Malmegrim RR, Fonseca FJ, OliveiraON, Mattoso LHC. A layer-by-layer film of chitosan in ataste sensor application. Macromol Biosci 2003;3:591–595.
23. Wood KC, Boedicker JQ, Lynn DM, Hammon PT. Tunabledrug release from hydrolytically degradable layer-by-layerthin films. Langmuir 2005;21:1603–1609.
24. Gu HF, He QL, Lin ZH, Liu L, Zhang XM. Effects of micro-filaments on basic fibroblast growth factor in regulatingwound healing. Chin J Traumatol 2000;16:331–333.
292 MA ET AL.
Journal of Biomedical Materials Research Part B: Applied BiomaterialsDOI 10.1002/jbmb